Unnecessary spending by health care entities on unproven COVID-19 treatments in the United States from January 2020 to December 2022

Journal of the American Pharmacists Association · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles